Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. Soc. Bras. Med. Trop ; 46(3): 310-315, May-Jun/2013. tab, graf
Article in English | LILACS | ID: lil-679529

ABSTRACT

Introduction Trypanosoma cruzi, a flagellated protozoan, is the etiologic agent of Chagas disease, and it is estimated that approximately 5 million people in Brazil are infected with this parasite. This work aimed to compare the current diagnostic methods for Chagas disease, including conventional serological (IFAT and ELISA) and molecular techniques (PCR), to introduce PCR as an auxiliary technique. Methods A total of 106 chagasic patients were evaluated: 88 from endemic areas of Parana, 6 from São Paulo, 3 from Minas Gerais, 3 from Rio Grande do Sul, 1 from Bahia and 5 from the Santa Catarina T. cruzi outbreak. The samples were analyzed by conventional serological methods (IFAT, ELISA), hemoculture and PCR to confirm Chagas disease. Results When IFAT was used to determine antibody levels, the sensitivity was 81.7% for patients with the cardiac form of the disease and 100% for the other clinical forms. In contrast, ELISA showed 84% sensitivity and 100% specificity. The use of serological and molecular techniques and their implications for the diagnosis of Chagas disease in non-endemics area are discussed. Conclusions PCR constitutes an excellent support methodology for the laboratory diagnosis of Chagas disease due to its high sensitivity and specificity. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Humans , Middle Aged , Young Adult , Antibodies, Protozoan/blood , Chagas Disease/diagnosis , DNA, Protozoan/analysis , Trypanosoma cruzi , Acute Disease , Case-Control Studies , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique, Indirect , Polymerase Chain Reaction , Sensitivity and Specificity , Trypanosoma cruzi/genetics , Trypanosoma cruzi/immunology
SELECTION OF CITATIONS
SEARCH DETAIL